Compared to those who did not suffer from severe hypoglycemia, patients with severe hypoglycemia at baseline had higher prescriptions of various anti-glucose drugs, including sulfonylurea, meglitinide, thiazolidinedione, alpha-glucosidase inhibitor, and insulin. This evidence concerns the gene GAA and Hypoglycemia.